What is the difference between Davunetide and Met-Enkephalin?

Davunetide: Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation. Met-Enkephalin: Binds OGF receptors (zeta opioid receptors) on cell nuclei, regulating DNA synthesis and cell proliferation in a tonic inhibitory manner. Also binds delta opioid receptors.

Is Davunetide FDA approved?

Davunetide is investigational and not FDA approved. It is discussed for research and educational purposes only, not as medical guidance.

Is Met-Enkephalin FDA approved?

Met-Enkephalin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Davunetide administered in research settings?

In research settings, Davunetide is typically administered via the intranasal or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

How is Met-Enkephalin administered in research settings?

In research settings, Met-Enkephalin is typically administered via the subcutaneous or intravenous routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Davunetide vs Met-Enkephalin

Peptide Comparison

Davunetide vs Met-Enkephalin

Both are Neuro & Cognitive peptides.

Davunetide

NAP

CognitiveInvestigationalResearch Only

No providers listed yet

Full Davunetide profile →

Met-Enkephalin

Methionine enkephalin

RecoveryNot EvaluatedResearch Only

5 providers listed

Full Met-Enkephalin profile →

Bottom line

Davunetide carries stronger published evidence (RCT, 3 key studies) than Met-Enkephalin (Cohort study, 2); both are research compounds.

Quick Verdict

Davunetide

Met-Enkephalin

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Davunetide
Further along in FDA review	Davunetide
More provider options (0 vs 5)	Met-Enkephalin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Davunetide

Met-Enkephalin

Mechanism Family

Neuro & Cognitive

Half-life

—

FDA Status

investigational

not evaluated

Admin Routes

intranasal, subcutaneous

subcutaneous, intravenous

Availability

Research Only

Providers

None listed

5 listed

Research Evidence

Davunetide

RCT · 3 key studies · most recent 2026

Met-Enkephalin

Cohort study · 2 key studies · most recent 2026

Research Citations

Davunetide

RCT2013 · Neuropsychopharmacology

Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with sch…

RCT2011 · Schizophrenia Research

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophren…

Animal2026 · Epilepsy Res

Microtubule-stabilizing drugs suppress convulsions in a C. elegans model of CAMSAP disorders.

Met-Enkephalin

Cohort2026 · Psychoneuroendocrinology

Endogenous opioid peptides in trichotillomania: An exploratory analysis of focused and automatic hair-pulling…

Review2015 · Biochemical Pharmacology

Duration of opioid receptor blockade determines biotherapeutic response

About Davunetide

Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.

Research Areas

neuroprotectiontau stabilizationcognitive enhancementmemorysynaptic plasticity

About Met-Enkephalin

Binds OGF receptors (zeta opioid receptors) on cell nuclei, regulating DNA synthesis and cell proliferation in a tonic inhibitory manner. Also binds delta opioid receptors. Intermittent blockade by low-dose naltrexone upregulates receptor expression and endogenous MENK tone.

Research Areas

immune modulationcell proliferation regulationanti-inflammatoryautoimmune support

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Davunetide

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Met-Enkephalin

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

Find Providers

Where to source these peptides

Providers offering

Davunetide

Browse directory →

Providers offering

Met-Enkephalin

5 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.